Bioequivalence Study of CJ-30060 in Healthy Male Volunteers

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The purpose of this study is to compare the pharmacokinetics and safety after a single dose administration of CJ‐30060 and Exforge® 10/160mg, Crestor® 20mg in healthy male volunteers.
Epistemonikos ID: 246d1706e5924f8109e995ca93afc1d2a59d7403
First added on: May 21, 2024